Coronavirus Infections: all 952 studies

Page 2 of 10. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.

• AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19TerminatedNCT04649775Not applicableResults posted
• A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19CompletedNCT04649151Phase 2/3Results posted
• A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19CompletedNCT04646044Phase 1Results posted
• The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging CampaignCompletedNCT04644328Not applicableResults posted
• Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 ExposureTerminatedNCT04642638Phase 2/3Results posted
• A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19CompletedNCT04622332Phase 1Results posted
• Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDSCompletedNCT04615429Phase 2Results posted
• Study to Evaluate Efficacy and Safety of "VIRACIDE" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)CompletedNCT04596085Not applicableResults posted
• Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy VolunteersCompletedNCT04588428Phase 2Results posted
• Mouth Rinses for Inactivation of COVID-19TerminatedNCT04584684Phase 2Results posted
• UVA Light Device to Treat COVID-19CompletedNCT04572399Not applicableResults posted
• Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19CompletedNCT04545047Results posted
• COVID-19 Risk Reduction Among African American ParishionersCompletedNCT04542343Not applicableResults posted
• Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19CompletedNCT04542226Results posted
• VA CoronavirUs Research and Efficacy Studies-1TerminatedNCT04539275Phase 3Results posted
• Coronavirus Induced Acute Kidney Injury: Prevention Using Urine AlkalinizationTerminatedNCT04530448Phase 4Results posted
• Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19CompletedNCT04527471Phase 2Results posted
• Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized PatientsCompletedNCT04524507Phase 2Results posted
• ACTIV-2: A Study for Outpatients With COVID-19CompletedNCT04518410Phase 2/3Results posted
• Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019TerminatedNCT04511650Phase 2Results posted
• A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) InfectionTerminatedNCT04508023Phase 3Results posted
• BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)CompletedNCT04494646Phase 2Results posted
• Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)CompletedNCT04487886Phase 2Results posted
• SPI-1005 Treatment in Severe COVID-19 PatientsCompletedNCT04483973Phase 2Results posted
• Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)CompletedNCT04478071Phase 2Results posted
• Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)TerminatedNCT04470622Phase 2Results posted
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)CompletedNCT04448756Phase 2Results posted
• NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)TerminatedNCT04442230Phase 2Results posted
• A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)TerminatedNCT04439071Phase 2/3Results posted
• ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)TerminatedNCT04432272Phase 2Results posted
• Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)CompletedNCT04427280Results posted
• Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19CompletedNCT04425252Phase 1/2Results posted
• A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19TerminatedNCT04421508Phase 3Results posted
• A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19TerminatedNCT04415073Phase 2Results posted
• A Study of Opaganib in Coronavirus Disease 2019 PneumoniaCompletedNCT04414618Phase 2Results posted
• Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 PatientsTerminatedNCT04409886Phase 4Results posted
• Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)TerminatedNCT04409873Phase 2Results posted
• Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)CompletedNCT04409509Phase 2Results posted
• A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19CompletedNCT04402060Phase 1/2Results posted
• hCT-MSCs for COVID19 ARDSTerminatedNCT04399889Phase 1/2Results posted
• COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy VolunteersCompletedNCT04392219Phase 1Results posted
• COVID-19 and Anti-CD14 Treatment TrialTerminatedNCT04391309Phase 2Results posted
• Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19CompletedNCT04391179Phase 2Results posted
• Early CPAP in COVID-19 Confirmed or Suspected PatientsTerminatedNCT04390191Not applicableResults posted
• Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal TrialCompletedNCT04390022Phase 2Results posted
• Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory FailureTerminatedNCT04389840Phase 2/3Results posted
• Convalescent Plasma for Patients With COVID-19CompletedNCT04385199Phase 2Results posted
• Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory SymptomsTerminatedNCT04382391Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19CompletedNCT04380961Phase 2Results posted
• Convalescent Plasma Collection and Treatment in Pediatrics and AdultsCompletedNCT04376034Phase 3Results posted
• Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary InjuryCompletedNCT04375397Phase 2Results posted
• Convalescent Plasma for Treatment of COVID-19 Patients With PneumoniaCompletedNCT04374565Phase 2Results posted
• COVID-19 Health Messaging to Underserved CommunitiesCompletedNCT04371419Not applicableResults posted
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy IndividualsCompletedNCT04368728Phase 2/3Results posted
• Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19TerminatedNCT04365985Phase 2Results posted
• Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19TerminatedNCT04365101Phase 1/2Results posted
• CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized PatientsCompletedNCT04364737Phase 2Results posted
• COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19TerminatedNCT04363437Phase 2Results posted
• Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19TerminatedNCT04362189Phase 2Results posted
• Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)CompletedNCT04359654Phase 2Results posted
• Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased OxygenationCompletedNCT04357782Phase 1/2Results posted
• Use of UC-MSCs for COVID-19 PatientsCompletedNCT04355728Phase 1/2Results posted
• Trial of Hydroxychloroquine In Covid-19 KineticsTerminatedNCT04353271Phase 2/3Results posted
• PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With HydroxychloroquineTerminatedNCT04353037Phase 2Results posted
• A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19CompletedNCT04349631Phase 2Results posted
• Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVIDTerminatedNCT04349371Phase 2Results posted
• Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 InfectionCompletedNCT04349098Phase 2Results posted
• A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.CompletedNCT04348435Phase 2Results posted
• BCG Vaccine for Health Care Workers as Defense Against COVID 19CompletedNCT04348370Phase 4Results posted
• Seroprevalence of SARS-Cov-2 Antibodies in ChildrenCompletedNCT04347408Results posted
• A Study of Auxora in Patients With Severe COVID-19 PneumoniaCompletedNCT04345614Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19CompletedNCT04343651Phase 2Results posted
• Convalescent Plasma in the Treatment of COVID 19CompletedNCT04343261Phase 2Results posted
• University of Utah COVID-19 Hydrochloroquine TrialCompletedNCT04342169Phase 2Results posted
• Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 InfectionTerminatedNCT04341727Phase 3Results posted
• CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 InfectionCompletedNCT04341584Phase 2Results posted
• Will Hydroxychloroquine Impede or Prevent COVID-19TerminatedNCT04341441Phase 3Results posted
• Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)CompletedNCT04341116Phase 2/3Results posted
• Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus)CompletedNCT04337489Results posted
• CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)CompletedNCT04331808Phase 2Results posted
• Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)CompletedNCT04328961Phase 2/3Results posted
• Pre-exposure Prophylaxis for SARS-Coronavirus-2CompletedNCT04328467Phase 3Results posted
• Sarilumab COVID-19CompletedNCT04327388Phase 3Results posted
• Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDSCompletedNCT04325906Not applicableResults posted
• Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARICompletedNCT04324073Phase 2/3Results posted
• Convalescent Plasma to Stem Coronavirus (CSSC-001)CompletedNCT04323800Phase 2Results posted
• Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory SyndromeCompletedNCT04323592Results posted
• Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)TerminatedNCT04322682Phase 3Results posted
• Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19TerminatedNCT04322396Phase 2Results posted
• Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)TerminatedNCT04318444Phase 2/3Results posted
• NO Prevention of COVID-19 for Healthcare ProvidersTerminatedNCT04312243Phase 2Results posted
• Losartan for Patients With COVID-19 Requiring HospitalizationCompletedNCT04312009Phase 2Results posted
• Intravenous Aviptadil for Critical COVID-19 With Respiratory FailureCompletedNCT04311697Phase 2/3Results posted
• Losartan for Patients With COVID-19 Not Requiring HospitalizationCompletedNCT04311177Phase 2Results posted
• Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2CompletedNCT04308668Phase 3Results posted
• Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19CompletedNCT04306393Phase 2Results posted
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19TerminatedNCT04305457Phase 2Results posted
• Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-SCompletedNCT03615911Phase 1Results posted
• Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy AdultsCompletedNCT02788188Phase 1Results posted
• Collection and Testing of Respiratory SamplesCompletedNCT01302418Results posted

← Coronavirus Infections overview